• Home • • The Food and Drug Administration (FDA) • • Datasets • • Drug Enforcements • • D-1438-2012 •

Drug Enforcement D-1438-2012

Presence of Particulate Matter: This product is being recalled due to the discovery of particles in the stability samples and retain samples.

Status

Terminated

Classification

Class II

Report Date

August 8, 2012

Termination Date

January 16, 2015

Product Information

Product description: Fosphenytoin Sodium Injection, USP, 500 mg PE per 10 mL (50 mg PE per mL), 10 mL Single Dose Vial, packaged in 10-count x 10 mL Single Dose Vials per carton, Rx only, Mfd. By: Hikma Farmaceutica (Portugal), S.A.; Dist. By: West-Ward Pharmaceutical Corp., Eatontown, NJ 07724 USA under the labels a) NOVAPLUS (NDC 0143-9703-10), b) West-Ward (NDC 0143-9782-10).
Product quantity: a) 74,960 vials; b) 911,070 vials
Reason for recall: Presence of Particulate Matter: This product is being recalled due to the discovery of particles in the stability samples and retain samples.
Recall initiation reason: —
Initial firm notification: Letter
Distribution pattern: All lots were distributed throughout the US.

Recall number: D-1438-2012
Event ID: 62627
Recall initiation date: April 13, 2012
Center classification date: August 2, 2012
Code info: Lot #s: a) 112161.1, 112162.1, 112163.1, Exp 05/13; b) 102165.2, 102167.1, Exp 05/12; 102190.1, 102191.1, 102191.2, 102192.1, 102213.1, Exp 07/12; 102240.1, 102241.1, 10227.1, 102272.1, 102272.2, 102273.1, 102274.1, 102275.1, Exp 09/12; 102319.1, 102320.1, 102321.1, 102322.1, 102323.1, 102324.1, 102325.1, Exp 11/12; 102342.1, 102343.1, 102344.1, 102345.1, Exp 12/12; 112019.1, 112020.1, 112021.1, 112022.1, 112023.1, Exp 01/13; 112156.1, 112157.1, 112158.1, 112159.1, 112160.1, Exp 05/13; 112164.1, Exp 06/13; 112203.1, 112204.1, 112205.1, 112206.1, Exp 07/13; 112262.1, 112263.1, Exp 09/13; 112301.1, 112302.1, 112303.1, 112304.1, Exp 10/13; 112323.1, 112324.1, 112325.1, Exp 11/13
More code info: —